Published in Mol Cell Endocrinol on July 31, 2002
Endocrine disrupters as obesogens. Mol Cell Endocrinol (2009) 2.80
Hyponatremia-induced osteoporosis. J Bone Miner Res (2010) 1.95
Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metab (2009) 1.79
Minireview: the case for obesogens. Mol Endocrinol (2009) 1.33
Estrogen Deficiency and the Origin of Obesity during Menopause. Biomed Res Int (2014) 1.08
Dietary isoflavones alter regulatory behaviors, metabolic hormones and neuroendocrine function in Long-Evans male rats. Nutr Metab (Lond) (2004) 1.06
A novel method for assessing sex-specific and genotype-specific response to injury in astrocyte culture. J Neurosci Methods (2008) 0.98
Analysis of the effect of estrogen/androgen perturbation on penile development in transgenic and diethylstilbestrol-treated mice. Anat Rec (Hoboken) (2013) 0.95
A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue. Reprod Biol Endocrinol (2009) 0.92
Mechanisms of G protein-coupled estrogen receptor-mediated spinal nociception. J Pain (2012) 0.91
Association of Prenatal Exposure to Persistent Organic Pollutants with Obesity and Cardiometabolic Traits in Early Childhood: The Rhea Mother-Child Cohort (Crete, Greece). Environ Health Perspect (2015) 0.90
Energy balance modulates colon tumor growth: Interactive roles of insulin and estrogen. Mol Carcinog (2010) 0.87
Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab (2008) 0.85
Indirect androgen doping by oestrogen blockade in sports. Br J Pharmacol (2008) 0.83
Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats. World J Urol (2009) 0.82
Challenges and future directions to evaluating the association between prenatal exposure to endocrine disrupting chemicals and childhood obesity. Curr Epidemiol Rep (2014) 0.81
The endocrine role of estrogens on human male skeleton. Int J Endocrinol (2015) 0.80
Influence of aromatase absence on the gene expression and histology of the mouse meibomian gland. Invest Ophthalmol Vis Sci (2013) 0.76
Roles of G protein-coupled estrogen receptor GPER in metabolic regulation. J Steroid Biochem Mol Biol (2017) 0.75
Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab (1995) 3.34
Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A (1998) 3.06
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A (2000) 2.83
Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med (1997) 2.52
Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology (1996) 2.30
Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. Ophthalmology (2001) 2.09
History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev (2009) 1.88
Aromatase expression in endometriosis. J Clin Endocrinol Metab (1996) 1.75
Estrogen and spermatogenesis. Endocr Rev (2001) 1.73
Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem (1989) 1.72
Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci U S A (1999) 1.64
A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab (1993) 1.60
Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab (1981) 1.55
Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab (1996) 1.49
A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab (1994) 1.47
Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science (1986) 1.45
Four Cases of Weil's Disease infected from Same Stream. Br Med J (1938) 1.40
Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci U S A (1993) 1.38
The cholesterol side-chain cleavage system of bovine adrenal cortex. Eur J Biochem (1967) 1.37
Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem (1993) 1.35
17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev (1991) 1.33
Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Cancer Res (2000) 1.31
An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology (2000) 1.31
A three-dimensional model of aromatase cytochrome P450. Protein Sci (1995) 1.30
Identification and characterization of cDNA clones specific for cholesterol side-chain cleavage cytochrome P-450. Proc Natl Acad Sci U S A (1984) 1.30
Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J Steroid Biochem Mol Biol (2001) 1.28
Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol Metab (1985) 1.27
Assay of aromatase activity. Methods Enzymol (1991) 1.25
Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology (2001) 1.25
Transcriptional regulation of steroid hydroxylase genes by corticotropin. Proc Natl Acad Sci U S A (1986) 1.23
Bovine adrenocortical cytochrome P-450(17 alpha). Regulation of gene expression by ACTH and elucidation of primary sequence. J Biol Chem (1986) 1.21
Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism. Int J Cancer (1981) 1.21
Partial resolution of the mixed-function oxidase involved in the cholesterol side-chain cleavage reaction in bovine adrenal mitochondria. Biochem Biophys Res Commun (1967) 1.19
Molecular cloning and amino acid sequence of the precursor form of bovine adrenodoxin: evidence for a previously unidentified COOH-terminal peptide. Proc Natl Acad Sci U S A (1985) 1.19
Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci U S A (1988) 1.16
Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis. Mol Cell Endocrinol (1979) 1.15
Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Mol Endocrinol (1991) 1.14
Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Mol Endocrinol (1995) 1.10
Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol Endocrinol (1996) 1.10
Tissue-specific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. J Biol Chem (1991) 1.08
Regulation by ACTH of steroid hormone biosynthesis in the adrenal cortex. Can J Biochem Cell Biol (1983) 1.07
Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture. J Steroid Biochem Mol Biol (1997) 1.06
Aromatase in aging women. Semin Reprod Endocrinol (1999) 1.06
Cholesterol synthesis in human fetal tissues. J Clin Endocrinol Metab (1982) 1.05
Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J Biol Chem (1995) 1.05
Endocrine physiology of the placenta. Annu Rev Physiol (1981) 1.05
Mitochondrial malic enzyme: the source of reduced nicotinamide adenine dinucleotide phosphate for steroid hydroxylation in bovine adrenal cortex mitochondria. Arch Biochem Biophys (1969) 1.04
Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab (1994) 1.01
Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res (2000) 1.01
A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene. Mol Cell Endocrinol (1997) 1.01
Regulation of the biosynthesis of cytochromes P-450 involved in steroid hormone synthesis. Mol Cell Endocrinol (1985) 1.01
Phytoestrogens in health and disease. Recent Prog Horm Res (1999) 1.00
Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticosteroids. Proc Natl Acad Sci U S A (1981) 1.00
The effect of ether anaesthesia stress on cholesterol-side-chain cleavage and cytochrome P450 in rat-adrenal mitochondria. Eur J Biochem (1972) 1.00
Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J Clin Endocrinol Metab (1994) 1.00
Immunohistochemical localization of aromatase cytochrome P-450 and estradiol dehydrogenase in the syncytiotrophoblast of the human placenta. J Clin Endocrinol Metab (1987) 1.00
The ovarian phenotype of the aromatase knockout (ArKO) mouse. J Steroid Biochem Mol Biol (2001) 0.99
Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms. Am J Obstet Gynecol (1981) 0.99
Lipoprotein utilization and cholesterol synthesis by the human fetal adrenal gland. Endocr Rev (1981) 0.98
The road to ovulation: the role of oestrogens. Reprod Fertil Dev (2001) 0.98
Upregulation of estrogen receptors in the forebrain of aromatase knockout (ArKO) mice. Mol Cell Endocrinol (2000) 0.98
Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 (P-450AROM), and their use in its purification. Arch Biochem Biophys (1985) 0.98
Expression of messenger ribonucleic acid species encoding steroidogenic enzymes in human follicles and corpora lutea throughout the menstrual cycle. J Clin Endocrinol Metab (1990) 0.98
Immunolocalization of aromatase, 17 alpha-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J Reprod Fertil (1989) 0.97
Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol Cell Endocrinol (1996) 0.97
Immunocytochemical distribution of aromatase cytochrome P450 in the rat brain using peptide-generated polyclonal antibodies. Endocrinology (1991) 0.97
Adenoma of the nonpigmented epithelium of the ciliary body. Can J Ophthalmol (1991) 0.97
Venovenous bypass in adult orthotopic liver transplantation: routine or selective use? J Am Coll Surg (1998) 0.96
Induction of synthesis of mitochondrial steroidogenic enzymes of bovine adrenocortical cells by analogs of cyclic AMP. J Biol Chem (1984) 0.96
Studies on the synthesis of sterol carrier protein-2 in rat adrenocortical cells in monolayer culture. Regulation by ACTH and dibutyryl cyclic 3',5'-AMP. J Biol Chem (1987) 0.95
Induction of synthesis of cholesterol side chain cleavage cytochrome P-450 by adrenocorticotropin in cultured bovine adrenocortical cells. J Biol Chem (1981) 0.95
Plasma lipoproteins in follicular fluid of human ovaries. J Clin Endocrinol Metab (1980) 0.95
Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem (1995) 0.95
Ultrasound biomicroscopic imaging of the anterior aspect of peripheral choroidal melanomas. Am J Ophthalmol (1997) 0.95
Defective internalization of low density lipoprotein in epidermoid cervical cancer cells. J Cell Biol (1982) 0.95
Immunohistochemical studies of steroidogenic enzymes (aromatase, 17 alpha-hydroxylase and cholesterol side-chain cleavage cytochromes P-450) in sex cord-stromal tumors of the ovary. Hum Pathol (1989) 0.94
Effects of adrenocorticotropin on 17 alpha-hydroxylase activity and cytochrome P-450(17 alpha) synthesis in bovine adrenocortical cells. J Biol Chem (1985) 0.94
Transcriptional regulation of the bovine CYP17 (P-450(17)alpha) gene. Identification of two cAMP regulatory regions lacking the consensus cAMP-responsive element (CRE). J Biol Chem (1990) 0.94
Aromatase gene expression in adipose tissue: relationship to breast cancer. J Steroid Biochem Mol Biol (1994) 0.94
Deoxycorticosterone biosynthesis in human kidney: potential for formation of a potent mineralocorticosteroid in its site of action. Proc Natl Acad Sci U S A (1980) 0.94
Spectral properties of rat adrenal-mitochondrial cytochrome P-450. Eur J Biochem (1974) 0.94
Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis. Mol Endocrinol (1993) 0.94
Regulation of steroid hydroxylase gene expression is multifactorial in nature. Recent Prog Horm Res (1989) 0.93
Simultaneous transfection of COS-1 cells with mitochondrial and microsomal steroid hydroxylases: incorporation of a steroidogenic pathway into nonsteroidogenic cells. Proc Natl Acad Sci U S A (1988) 0.93
Angiotensin II inhibits luteinizing hormone-stimulated cholesterol side chain cleavage expression and stimulates basic fibroblast growth factor expression in bovine luteal cells in primary culture. J Biol Chem (1990) 0.93
The detection of different states of the P-450 cytochromes in adrenal mitochondria: changes induced by ACTH. Ann N Y Acad Sci (1973) 0.93
Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report. J Steroid Biochem Mol Biol (2003) 0.93
Regulation of cholesterol and progesterone synthesis in human placental cells in culture by serum lipoproteins. Endocrinology (1980) 0.93
Structural characterization of normal and mutant human steroid 17 alpha-hydroxylase genes: molecular basis of one example of combined 17 alpha-hydroxylase/17,20 lyase deficiency. Mol Endocrinol (1988) 0.92
Conversion of plasma progesterone to deoxycorticosterone in men, nonpregnant and pregnant women, and adrenalectomized subjects. J Clin Invest (1980) 0.92
Regulation of aromatase expression in human tissues. Breast Cancer Res Treat (1994) 0.91
Steroidogenic factor 1 (SF-1) and SP1 are required for regulation of bovine CYP11A gene expression in bovine luteal cells and adrenal Y1 cells. Mol Endocrinol (1997) 0.91
Regulation of cytochrome P-45011 beta gene expression by adrenocorticotropin. J Biol Chem (1985) 0.91
Cell-free synthesis of precursor forms of mitochondrial steroid hydroxylase enzymes of the bovine adrenal cortex. Arch Biochem Biophys (1982) 0.90
Endocrine disorders associated with inappropriately high aromatase expression. J Steroid Biochem Mol Biol (1997) 0.90
Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification. J Clin Endocrinol Metab (1992) 0.89